Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas

Cancer Letters

Volumn 122, Issue 1-2, 1998, Pages 165-175

  Robertson, Fredika M ^a   Parrett, Michelle L ^a   Joarder, Farahnaz S ^b   Ross, Mary ^a   Abou Issa, Hussein M ^c   Alshafie, Galal ^c   Harris, Randall E ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

COX; Ibuprofen; Mammary carcinoma; NSAIDs; Prostaglandin G H synthase

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ANIMALIA; RODENTIA;

EID: 0032498246     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00387-X     Document Type: Article

References (40)

1. Fulton A.M. In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res. 44:1984;2416-2420.
2. Carter C.A., Ip M.M., Ip C. A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen in 7,12 dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acids. Carcinogenesis. 10:1989;1369-1374.
3. Lee P.P., Ip M.M. Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase. Prostaglan. Leukotrien. Essen. Fat. Acid. 45:1992;21-31.
4. Noguchi M., Rose D.P., Earachi M., Miyazaki I. The role of fatty acids and eicoasanoid synthesis inhibitors in breast carcinoma. Oncology. 52:1995;265-271.
5. Carter C.A., Milholland R.J., Shea W., Ip M.M. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12 dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different levels fat. Cancer Res. 45:1983;3559-3562.
6. Honn K.V., Bockman R.S., Marnett L.J. Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins. 21:1981;833-864.
7. Bennett A., Charlier E.M., McDonald A.M., Simpson J.S., Stamford I.F., Zebro T. Prostaglandins and breast cancer. Lancet. 27:1977;624-626.
8. Bennett A. The production of prostanoids in human cancers and their implications for tumor progression. Prog. Lipid Res. 25:1986;539-542.
9. Bennett A., Berstock D.A., Raja B., Stamford I.F. Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers. Br. J. Pharmacol. 66:1979;451P.
10. Rolland P.H., Martin P.M., Jacquemeier J., Rolland A.M., Toga M. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst. 64:1980;1061-1070.
11. Marnett L.J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52:1992;5575-5589.
12. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:1996;33157-33160.
13. Williams C.S., DuBois R.N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270:1996;G393-G400.
14. Herschman H.R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 13:1994;241-256.
15. O'Neill G.P., Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330:1993;156-160.
16. Wallace J.L. Prostaglandins, NSAIDs, and cytoprotection. Gastroenterol. Clin. North Am. 21:1992;L631-L641.
17. Wu K.K. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. J. Lab. Clin. Med. 128:1996;242-245.
18. Herschman H.R. Prostaglandin synthase 2. Biochem. Biophys. Acta. 1299:1996;125-140.
19. Cohen L.A., Karmali R.A. Endogenous prostaglandin production by established cultures of neoplastic rat mammary epithelial cells. In Vitro. 20:1984;119-126.
20. Karmali R.A., Marsh J. Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2. Prostaglandins Leukotrienes Med. 23:1986;11-14.
21. Parrett M.L., Harris R.E., Joarder F.S., Ross M.S., Clausen K.P., Robertson F.M. Cyclooxygenase gene expression in human breast cancer. Int. J. Oncol. 10:1997;503-507.
22. Parrett M., Harris R.E., Joarder F.S., Ross M.S., Clausen K.P., Robertson F.M. COX-2 gene expression, NSAIDs intake, and human breast cancer. Proc. Am. Assoc. Cancer Res. 38:1997;570.
23. Subbaramaiah K., Terlang N., Ramonetti J.T., Araki R., DeVito B., Weksler B.B., Dannenberg A.J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 56:1996;4424-4429.
24. Liu X.-H., Rose D.P. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res. 56:1996;5125-5127.
25. Harris R.E., Namboodiri K.K., Stellman S.D., Wynder E.L. Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev. Med. 24:1995;119-120.
26. Harris R.E., Namboodiri K.K., Farrar W.B. Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology. 7:1996;203-205.
27. Harris R.E., Namboodiri K.K., Farrar W.B. Epidemiological study of nonsteroidal antiinflammatory drugs and breast cancer. Oncol. Rep. 2:1995;591-592.
28. G.W. Snedecar, G.W. Cochran, Statistical Methods, Iowa State University Press, Ames, IA, 1971, p. 593.
29. Rose D.P., Hatala M.A., Connelly J.M., Rayburn J. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res. 53:1993;4686-4690.
30. Liu X.-H., Connelly J.M., Rose D.P. Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line. Clin. Exp. Metastasis. 14:1996;145-152.
31. Rose D.P., Connolly J.M., Liu X.H. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res. 54:1994;6557-6562.
32. Plesia O.J., Smith A.H., Grinwich K. Submersion of immune system by tumor cells and role of prostaglandins. Proc. Natl. Acad. Sci. USA. 72:1975;1848-1851.
33. Fulton A.M., Levy J.G. The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells. Cell. Immunol. 52:1980;29-37.
34. Fulton A.M. Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells. Prostaglandins. 35:1988;413-425.
35. Shapiro A.C., Wu D., Meydani S.N. Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative responses. Prostaglandins. 45:1993;229-240.
36. Khoo N.K.S., Chan F.P.H., Saarloos M.N., Lala P.K. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone and in combination with IL-2. Clin. Exp. Metastasis. 10:1992;239-252.
37. Gustafson-Svärd C., Lilja I., Hallböök O., Sjödahl R. Cyclooxygenase-1 and cyclooxygenase-2 expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut. 38:1996;79-84.
38. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:1992;25934-25938.
39. Smith W.L., Meade E.A., DeWitt D.L. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann. N. Y. Acad. Sci. 744:1994;50-57.
40. Reddy S.T., Herschman H.R. Transcellular prostaglandin production following mast cell activation is mediated by proximal secretory phospholipase A2 and distal prostaglandin synthase 1. J. Biol. Chem. 271:1996;186-191.